Overview
Elizabeth Plimack is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Plimack and is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. Her top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Orchiectomy.
Her clinical research consists of co-authoring 223 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles in the study of Muscle Invasive Bladder Cancer.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Humana
Locations
3401 N Broad St, Philadelphia, PA 19140
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Temple Faculty Practice Plan Inc
Daniel Geynisman is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Geynisman and is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Urothelial Cancer, and Nephrectomy.
Temple Faculty Practice Plan Inc
Matthew Zibelman is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Zibelman and is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Endoscopy.
Temple Faculty Practice Plan Inc
Fern Anari is an Oncologist in Philadelphia, Pennsylvania. Dr. Anari and is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. Her top areas of expertise are Muscle Invasive Bladder Cancer, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, and Tissue Biopsy.
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Distinguished
- Adult Soft Tissue Sarcoma
- Chromophobe Renal Cell Carcinoma
- Clear Cell Sarcoma
- Familial Prostate Cancer
- Familial Wilms Tumor 2
- Non-Muscle Invasive Bladder Cancer
- Experienced
- Bone Tumor
- Desmoplastic Small Round Cell Tumor
- Lymphofollicular Hyperplasia
- Melanoma
- Metastatic Brain Tumor
- Metastatic Pleural Tumor